RBC Bearings Incorporated RBC R3K
Company Overview
RBC Bearings Incorporated manufactures and markets engineered precision bearings, components, and systems in the United States and internationally. It operates through two segments: Aerospace/Defense and Industrial. The company produces plain bearings with self-lubricating or metal-to-metal designs, including rod end bearings, spherical plain bearings, and journal bearings; roller bearings, such as tapered roller bearings, needle roller bearings, and needle bearing track rollers and cam followers, which are anti-friction products that are used in industrial applications and military aircraft platforms; and ball bearings that include high precision aerospace, airframe control, thin section, and industrial ball bearings that utilize high precision ball elements to reduce friction in high-speed applications. In addition, it offers mounted bearing products include mounted ball bearings, mounted roller bearings, and mounted plain bearings; and enclosed gearing product lines, including quantis gearmotor, torque arm, tigear, magnagear and maxum, and controlled start transmission. Further, the company's power transmission components include mechanical drive components, couplings, and conveyor components; engineered hydraulics and valves for aircraft and submarine applications, and aerospace and defense aftermarket services; fasteners; precision mechanical components, for use in various general industrial applications; and machine tool collets that are used for holding circulars or rod-like pieces. It serves commercial and defense aerospace,, construction, mining, forestry, energy, agricultural, food and beverage, metals and mining material handling, chemicals, oil and gas production, warehousing and logistics, semiconductor equipment, waste and water management, and rail and transportation applications through its direct sales force, and a network of industrial and aerospace distributors. The company was founded in 1919 and is based in Oxford, Connecticut.
Why Investors Should Care
Net profit has compounded at 12.5% per year over the last five years.
Maintains a net profit margin of 16.4%.
Carries low leverage with a debt-to-equity ratio of 0.25.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Mar 2026 Revenue of $1.87B (+14.3% YoY); net profit $287.60M.
- Trailing 12 Months Year-on-year growth — revenue +19.2%, earnings +47.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 9.7%, profit CAGR 12.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 9.66% |
| 1 Year: | 19.20% |
Compounded Profit Growth
| 5 Years: | 12.51% |
| 1 Year: | 47.50% |
Stock Price Performance
| 1 Year: | +26.96% |
| 6 Months: | -12.98% |
| 3 Months: | -16.71% |
| 1 Month: | -13.23% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)31.97 · Neutral
P/E of 48.54 is above the sector median of 26.00 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 12.5% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | RBC RBC Bearings Incorporated R3K | 492.23 | 48.54 | $15.58B | 0.00% | 9.44% | 9.75% | 9.66% | 12.51% |
| 2 | SPCX Space Exploration Technologies Corp. R3KAIDEFENCE | 153.47 | -139.52 | $1.16T | 0.00% | -3.22% | -11.95% | 34.08% | -3.34% |
| 3 | CAT Caterpillar Inc. SPXR3K | 822.48 | 35.47 | $378.07B | 0.79% | 17.98% | 56.97% | 2.29% | 5.24% |
| 4 | GE GE Aerospace SPXR3KDEFENCE | 334.91 | 39.40 | $347.49B | 0.60% | 9.52% | 48.23% | -7.42% | -5.36% |
| 5 | RTX RTX Corporation SPXR3KDEFENCE | 198.81 | 35.06 | $267.95B | 1.51% | 8.28% | 12.27% | 2.61% | 2.62% |
| 6 | GEV GE Vernova Inc. SPXR3KAI | 971.31 | 27.86 | $258.69B | 0.22% | 6.30% | 82.58% | 8.68% | - |
| 7 | DE Deere & Company SPXR3K | 680.73 | 37.88 | $183.54B | 0.95% | 12.53% | 18.24% | 3.43% | 5.10% |
| 8 | UNP Union Pacific Corporation SPXR3K | 288.45 | 23.38 | $171.36B | 2.01% | 15.22% | 39.70% | 2.30% | 7.77% |
| 9 | BA The Boeing Company SPXR3KDEFENCE | 210.73 | 75.80 | $166.43B | 0.00% | -9.01% | - | 1.67% | -3.28% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2013 | Jun 2014 | Sep 2014 | Dec 2014 | Jun 2015 | Sep 2015 | Dec 2015 | Jul 2016 | Oct 2016 | Dec 2016 | Jul 2017 | Sep 2017 | Dec 2017 | Jun 2018 | Sep 2018 | Dec 2018 | Jun 2019 | Sep 2019 | Dec 2019 | Jun 2020 | Sep 2020 | Dec 2020 | Jul 2021 | Oct 2021 | Jan 2022 | Jul 2022 | Oct 2022 | Dec 2022 | Jul 2023 | Sep 2023 | Dec 2023 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 146.34M | 145.86M | - | 160.90M | 266.95M | - | - | - | - | - | - | - | - | - | - | 436.00M | 455.30M | 461.60M | 518.00M | 519.50M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 240.80M | 254.70M | 257.20M | 288.00M | 271.70M |
| Gross Profit | 38.50M | 43.82M | 39.75M | 41.65M | 52.76M | 52.12M | 53.52M | 57.25M | 56.73M | 52.38M | 62.02M | 61.92M | 64.77M | 67.74M | 67.82M | 68.13M | 70.69M | 71.11M | 70.71M | 59.45M | 56.60M | 55.59M | 63.77M | 62.46M | 93.34M | 141.20M | 151.10M | 146.00M | 167.90M | 166.30M | 158.00M | 184.00M | 173.80M | - | - | 195.20M | 200.60M | 204.40M | 230.00M | 247.80M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 91.80M | 98.10M | 98.90M | 109.40M | 106.80M |
| Operating Income | 19.66M | 24.21M | 18.30M | 20.59M | 22.36M | 23.60M | 27.05M | 29.22M | 29.55M | 20.53M | 31.96M | 25.44M | 33.28M | 36.00M | 35.88M | 19.84M | 38.49M | 37.31M | 37.47M | 28.81M | 26.36M | 26.54M | 29.31M | 16.57M | 15.87M | 64.50M | 72.00M | 70.40M | 85.00M | 87.80M | 75.20M | 97.50M | 86.10M | - | - | 103.40M | 102.50M | 105.50M | 120.60M | 141.00M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 129.50M | 129.70M | 135.20M | 153.50M | 173.60M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 12.20M | 13.40M | 13.00M | 11.20M | 10.10M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 87.70M | 83.40M | 89.30M | 108.90M | 130.20M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 19.20M | 23.40M | 21.90M | 17.20M | 28.70M |
| Net Income | 12.76M | 16.02M | 13.25M | 14.05M | 13.40M | 14.52M | 17.05M | 18.04M | 18.23M | 12.77M | 21.81M | 14.82M | 23.83M | 27.47M | 30.11M | 16.18M | 30.50M | 31.27M | 30.52M | 22.69M | 20.42M | 21.57M | 24.04M | -1.35M | 546.00K | 37.40M | 43.80M | 36.30M | 50.00M | 51.70M | 46.60M | 61.40M | 54.20M | - | - | 68.50M | 60.00M | 67.40M | 91.70M | 101.50M |
| Diluted EPS | 0.55 | 0.69 | 0.57 | 0.60 | 0.57 | 0.62 | 0.73 | 0.76 | 0.77 | 0.54 | 0.90 | 0.61 | 0.97 | 1.12 | 1.22 | 0.65 | 1.23 | 1.26 | 1.22 | 0.91 | 0.82 | 0.86 | 0.95 | -0.07 | -0.18 | 1.09 | 1.31 | 1.05 | 1.52 | 1.58 | 1.39 | 1.90 | 1.65 | - | - | 2.17 | 1.90 | 2.13 | 2.89 | 3.20 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2009 | Apr 2010 | Apr 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Apr 2016 | Apr 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Apr 2021 | Mar 2022 | Apr 2022 | Mar 2023 | Apr 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 355.80M | 274.70M | 335.62M | 397.51M | 403.05M | 418.89M | 445.28M | 597.47M | 615.39M | 674.95M | 702.52M | 727.46M | 609.00M | - | 942.90M | 1.47B | 1.47B | 1.56B | 1.64B | 1.87B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 864.50M | - | 889.80M | 910.20M | 1.04B |
| Gross Profit | 118.22M | 84.57M | 109.77M | 140.58M | 152.93M | 164.80M | 170.14M | 218.78M | 230.21M | 258.54M | 276.65M | 289.10M | 234.10M | - | 357.10M | 604.80M | 604.80M | 670.50M | 726.10M | 830.20M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 299.60M | - | 324.10M | 352.30M | 398.20M |
| Operating Income | 54.97M | 34.67M | 56.19M | 77.65M | 78.10M | 88.65M | 88.43M | 103.84M | 114.59M | 128.77M | 132.03M | 156.78M | 114.60M | - | 121.10M | 305.20M | 293.00M | 346.40M | 373.80M | 432.00M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 401.80M | - | 459.80M | 491.70M | 547.90M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 76.70M | - | 78.70M | 59.80M | 49.80M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 209.70M | - | 261.80M | 311.90M | 369.30M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 43.00M | - | 51.90M | 65.70M | 81.70M |
| Net Income | 34.45M | 24.39M | 34.87M | 50.00M | 56.34M | 60.21M | 58.25M | 63.89M | 70.62M | 87.14M | 105.19M | 126.04M | 90.10M | - | 54.70M | 166.70M | 166.70M | 209.90M | 246.20M | 287.60M |
| Diluted EPS | 1.58 | 1.12 | 1.58 | 2.23 | 2.47 | 2.59 | 2.49 | 2.72 | 2.97 | 3.58 | 4.26 | 5.06 | 3.58 | - | 1.56 | 4.94 | 4.94 | 6.41 | 7.70 | 9.09 |
| R&D Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 27.60M | - | 31.80M | 33.00M | 33.00M | 34.40M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2008 | Mar 2009 | Apr 2010 | Apr 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Apr 2016 | Mar 2017 | Apr 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Apr 2021 | Mar 2022 | Apr 2022 | Mar 2023 | Apr 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 375.95M | 425.98M | 459.52M | 542.44M | 620.99M | 632.07M | 1.10B | - | 1.11B | 1.14B | 1.15B | 1.32B | 1.43B | - | 4.85B | 4.69B | 4.69B | 4.68B | 4.69B | 5.12B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 913.30M | - | 965.50M | 1.03B | 1.19B |
| Cash & Equivalents | 9.86M | 30.56M | 21.39M | 63.98M | 68.62M | 114.48M | 121.21M | 125.45M | 39.21M | 38.92M | 38.92M | 54.16M | 29.88M | 103.25M | 151.09M | - | 182.90M | 65.40M | 65.40M | 63.50M | 36.80M | 57.30M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 587.20M | - | 622.80M | 654.50M | 762.80M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 239.60M | - | 255.20M | 307.60M | 340.60M |
| Total Liabilities | - | - | 92.41M | 95.92M | 73.70M | 80.25M | 82.54M | 82.64M | 477.56M | - | 391.80M | 308.20M | 178.80M | 203.91M | 204.31M | - | 2.47B | 2.15B | 2.15B | 1.93B | 1.65B | 1.76B |
| Current Liabilities | - | - | 31.79M | 69.55M | 43.86M | 46.57M | 42.82M | 42.02M | 88.32M | - | 93.14M | 105.20M | 90.13M | 103.75M | 88.24M | - | 313.50M | 309.30M | 309.30M | 294.30M | 315.30M | 546.20M |
| Long Term Debt | - | - | 37.00M | 750.00K | 0 | 9.06M | 9.17M | 7.96M | 353.21M | - | 255.59M | 154.12M | 43.18M | 16.58M | 13.49M | - | 1.69B | 1.39B | 1.39B | 1.19B | 918.40M | 701.70M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.49B | - | 1.29B | 1.03B | 991.40M |
| Total Equity | 223.91M | 256.01M | 283.55M | 330.07M | 385.81M | 462.19M | 538.45M | 549.43M | 620.95M | 717.04M | 717.04M | 834.55M | 968.57M | 1.12B | 1.23B | - | 2.37B | 2.54B | 2.54B | 2.75B | 3.03B | 3.36B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 29.99M | - | 30.23M | 32.52M | 32.72M |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2009 | Apr 2010 | Apr 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Apr 2016 | Apr 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Apr 2021 | Mar 2022 | Apr 2022 | Mar 2023 | Apr 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 44.74M | 41.15M | 49.96M | 45.03M | 66.26M | 47.98M | - | 83.36M | 101.24M | 130.29M | 108.55M | 155.62M | 152.40M | - | 180.30M | 220.60M | 220.60M | 274.70M | 293.60M | 415.70M |
| Investing Cash Flow | -33.34M | -19.05M | -4.84M | -13.66M | -45.18M | -47.12M | - | -520.14M | -21.36M | -27.89M | -17.14M | -62.78M | -101.50M | - | -2.85B | -14.00M | -14.00M | -52.20M | -49.80M | -349.70M |
| Financing Cash Flow | 9.92M | -31.39M | -5.38M | -27.39M | 28.65M | 3.78M | - | 349.79M | -78.77M | -89.94M | -113.28M | -20.37M | -3.40M | - | 2.70B | -322.80M | -322.80M | -223.50M | -270.40M | -43.30M |
| Capital Expenditure | -27.58M | -9.91M | -10.44M | -17.84M | -42.02M | -28.92M | -20.90M | -20.86M | -20.89M | -27.98M | -41.35M | -37.30M | -11.80M | - | -29.80M | -42.00M | -42.00M | -33.20M | -49.80M | -73.10M |
| Free Cash Flow | 17.16M | 31.25M | 39.52M | 27.19M | 24.25M | 19.05M | - | 62.50M | 80.35M | 102.31M | 67.20M | 118.32M | 140.60M | - | 150.50M | 178.60M | 178.60M | 241.50M | 243.80M | 342.60M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -116.20M | - | -1.00M | -26.60M | 22.70M |
| Share Buybacks | 569.00K | 862.00K | 550.00K | 629.00K | 4.25M | 1.79M | 7.06M | 10.49M | 4.75M | 4.99M | 5.23M | 12.21M | 6.80M | - | 8.60M | - | 7.70M | 11.00M | 9.50M | - |
| Dividends Paid | - | - | - | - | - | 0 | 46.01M | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Mar 2009 | Apr 2010 | Apr 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Apr 2016 | Apr 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Apr 2021 | Mar 2022 | Apr 2022 | Mar 2023 | Apr 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 33.2% | 30.8% | 32.7% | 35.4% | 37.9% | 39.3% | 38.2% | 36.6% | 37.4% | 38.3% | 39.4% | 39.7% | 38.4% | - | 37.9% | 41.2% | 41.2% | 43.0% | 44.4% | 44.4% |
| Operating Margin % | 15.4% | 12.6% | 16.7% | 19.5% | 19.4% | 21.2% | 19.9% | 17.4% | 18.6% | 19.1% | 18.8% | 21.6% | 18.8% | - | 12.8% | 20.8% | 19.9% | 22.2% | 22.8% | 23.1% |
| Net Margin % | 9.7% | 8.9% | 10.4% | 12.6% | 14.0% | 14.4% | 13.1% | 10.7% | 11.5% | 12.9% | 15.0% | 17.3% | 14.8% | - | 5.8% | 11.3% | 11.3% | 13.5% | 15.0% | 15.4% |
| ROE % | 13.5% | 8.6% | 10.6% | 13.0% | 12.2% | 11.2% | 10.6% | 10.3% | 9.8% | 10.4% | 10.9% | 11.2% | 7.3% | - | 2.3% | 6.6% | 6.6% | 7.6% | 8.1% | 8.6% |
| ROCE % | - | 10.1% | 15.8% | 18.7% | 15.8% | 15.3% | 15.0% | 10.3% | 11.3% | 12.4% | 12.5% | 12.9% | 8.5% | - | 2.7% | 7.0% | 6.7% | 7.9% | 8.6% | 9.4% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 9.62% | 3.05M | $1.53B |
| 2 | Durable Capital Partners Lp | 5.40% | 1.71M | $856.19M |
| 3 | Vanguard Capital Management LLC | 4.51% | 1.43M | $716.03M |
| 4 | Vanguard Portfolio Management LLC | 4.19% | 1.33M | $664.77M |
| 5 | FMR, LLC | 4.17% | 1.32M | $661.52M |
| 6 | Kayne Anderson Rudnick Investment Management LLC | 3.82% | 1.21M | $605.52M |
| 7 | State Street Corporation | 3.06% | 967.19K | $484.57M |
| 8 | BAILLIE GIFFORD & CO | 2.40% | 760.47K | $381.00M |
| 9 | Geode Capital Management, LLC | 2.23% | 704.97K | $353.20M |
| 10 | Invesco Ltd. | 2.03% | 644.04K | $322.67M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for RBC
Biohaven Shares Fall After RBC Downgrades Stock and Cuts Price Target - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNM1UyRjJiUUFvSlE5YzE3ejFDU01OanJqOTVFM2w2eHhsYXdUNkVVT1M1bDZtRjdBQmpzd1NXUDkzeWlrTlJVZnlEVF9aaHBtaTRKYWVnZXVRb2xPWlhiX0podnI0OUdpVUUzU3BNY0NJVXh3MmNMMTBmcjd6MkpEUXVTN09JbVZyaG9sRU…
Biohaven Pharma stock falls after RBC Capital downgrade - Investing.com
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxPTWJxb3plNi1aOTJtSFk2S0ZBdnI2UkJQdTIwQWNkaDJQZFlyX1NtNUJCemZlN2E2azhZSTRHb2dOMDNubjN0NGJoTGdQM0ROZ0dCZS1mMDM4c0hBd1JHbzVvUDFDaWJFVEYyaHpnX1JyYlUwdkRjTVJ4U1E4Zk5WYm5uZUlsekVpWkpSSE…
Biohaven Stock Seen Range-Bound as Near-Term Catalysts Fade, RBC Says - marketscreener.com
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxOdmlEdDdqZnVvYjdfaXhTaUhnNGRRalNBemw2ZWduSjdOdUhQN3hHUm5IUzNtM19TLWdNb2RMRGZUaW5RYnRkYkRPQ3ppaVBlUC1fbXlrczZIX25uWXo5MTFHbEUzMkxyeE9hai1NVlJTRzFfUC1waG9wQWxRUUpTTWllejNNaHdxODZBZG…
RBC Bearings (RBC) Stock Looks Stretched On Cash Flow And Earnings - simplywall.st
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxPQ2IxOVFVTEpGWWF5bGZodWl4Mjd6SE5MX1Z4Q240WTFuOE5wM1dmMHViUk52N1pPQUlzaUIwdkFfUllwQUk0ZHFpdnVNTTg0a3dBaVpQbVdmV0hKeG13RlZiMG1mMk1oVmlCS3ZpeEwwZDdqSEs1QVZicUdCNUctNmVreVhPdzVrMWU1aj…
Colgate-Palmolive's (CL) "Outperform" Rating Reiterated at Royal Bank Of Canada - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxQbHE5eE5CZEpFamNrWWVENGg0Slp2REFhemplZU4yRmQ4UGdKZFpYa1ZqbE5QcDBZUW01eHVvazdpWWRUdEUza1QyM0pyTUpyakZIaHFlcUZDQmVtSkplN042N1VRRjhTYlFVWnZNOGpJRENEVXA1OWNNNHVMOGZUZkZpY3otRjNLclp2dm…
Royal Bank of Canada Earnings: Net Interest Income Growth Lags Peers - Morningstar
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOYkpWbVREVGFHS2xaQktrRWlnRXF0OWtFMGpUUUxhaURXTFhZNmU2SW9MRlhwT1A0NVI1aUNSUzh1X3JFbUlCWDQxcFNyai1vaEhkSzN4M3I1b3BBdlpGUEZpTk1ZNi1IblRhVk9rT183Wlk5M24yUG9wdkliazQ5dkFzNm9GR3FEUENZVj…
RBC — Frequently Asked Questions
What is the current share price of RBC Bearings Incorporated (RBC)?
As of 2026-09-19 21:16 PDT, RBC Bearings Incorporated (RBC) trades at $492.23 on NYSE. Its 52-week range is $369.71 to $648.89.
What is the market capitalisation of RBC?
RBC Bearings Incorporated (RBC) has a market capitalisation of $15.58B on NYSE.
What is the P/E ratio of RBC?
RBC trades at a trailing price-to-earnings (P/E) ratio of 48.54. The industry average P/E is 26.00. Its price-to-book (P/B) ratio is 4.57.
What is the return on equity (ROE) of RBC?
RBC has a return on equity (ROE) of 9.75%. Its return on capital employed (ROCE) is 9.44%.
Is RBC a good stock to buy?
This page provides a data-driven analysis of RBC Bearings Incorporated (RBC), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.